Aerocrine

Aerocrine completes $50M debt and equity financing

Wednesday, May 1, 2013

Aerocrine, a medical products company, has completed a financing with an affiliate of the U.S. investment firm OrbiMed Advisors and with Novo consisting of $35 million of debt. Aerocrine also raised $ 15 million of equity from OrbiMed and a number of institutional investors through a directed share issue.

[Read More]